SCHEMBL29469893

SCHEMBL29469893

CCOc1ccc(C(C)C)cc1S(N)(=O)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.59
▸ TSHR P16473 3/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ ALPL P05186 1/20 0.54
▸ CA12 O43570 3/20 0.51
▸ CA1 P00915 3/20 0.51
▸ CA2 P00918 3/20 0.51
▸ CA9 Q16790 3/20 0.51
▸ CA14 Q9ULX7 1/20 0.51
▸ MEN1 O00255 1/20 0.47
▸ ADRB2 P07550 1/20 0.45
▸ ADRB1 P08588 1/20 0.45
▸ HTR1A P08908 1/20 0.45
▸ ADRA2A P08913 1/20 0.45
▸ DRD2 P14416 1/20 0.45
▸ ADRA2B P18089 1/20 0.45
▸ ADRA2C P18825 1/20 0.45
▸ ADRA1D P25100 1/20 0.45
▸ HTR2A P28223 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22587940 0.89 CA1 (0.50) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL741127 0.84 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL22588435 0.82 ADRA1D (0.48) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL31411917 0.82 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2TSHRCA12CA1
SCHEMBL10642055 0.82 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2TSHRCA12CA1
SCHEMBL22588505 0.81 ADRA1D (0.52) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL22588071 0.81 RORC (0.46) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL29588239 0.81 ADRA1D (0.52) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL29587949 0.81 RORC (0.46) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL29469925 0.79 MEN1 (0.58) ALDH1A1SMN1; SMN2TSHRKMT2AALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 — — EP disclosed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 — — EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 — — WO disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 — — WO disclosed
Send feedback